High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment
Susan L. Heatley(ANZCHOG), Deborah L. White(ANZCHOG), Murray D. Norris(Cancer Clinic), Walter Muskovic(Children's Cancer Institute Australia), Kelly Quek(South Australian Health and Medical Research Institute), Andrew S. Moore(Children's Health Queensland Hospital and Health Service), Barbara J. McClure(South Australian Health and Medical Research Institute), Frank Alvaro(ANZCHOG), Teresa Sadras(South Australian Health and Medical Research Institute), Eva Nievergall(South Australian Health and Medical Research Institute), Charles G. Mullighan(St. Jude Children's Research Hospital), Timothy P. Hughes(Royal Adelaide Hospital), Jeffrey C. Suttle(South Australia Pathology), Chung Hoow Kok(South Australian Health and Medical Research Institute), Nicola C. Venn(Children's Cancer Institute Australia), Rosemary Sutton(UNSW Sydney), Glenn M. Marshall(The University of Sydney), Tamás Révész(Women's and Children's Hospital), Sarah Moore(South Australia Pathology), Chris Fraser(Children’s Health Queensland Hospital and Health Service), Tamara Law(Children's Cancer Institute Australia), Luciano Dalla Pozza(ANZCHOG), Anthea Ng(ANZCHOG), Ram Suppiah(Mater Children's Hospital), Michael Osborn, Phuong Dang(South Australia Pathology), David T Yeung(Royal Adelaide Hospital)
Cited by 62
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
|Nature Genetics|2017|934